Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic
fibroblast-like cells that can differentiate into cells of multiple lineages, such as …

Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of
cardiovascular diseases owing to their low immunogenicity, ease of isolation and …

Bone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to
phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in …

Although many therapeutic interventions have shown promise in treating spinal cord injury,
focusing on a single aspect of repair cannot achieve successful and functional regeneration …

Mesenchymal stem cell (MSC) therapy offers great potential for treatment of disease through
the multifunctional and responsive ability of these cells. In numerous contexts, MSC have …

Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease
(PAD), it is characterized by progressive blockade of arterial vessels, commonly correlated …

Introduction Critical limb ischemia (CLI) is the most advanced form of peripheral arterial
disease (PAD) characterized by ischemic rest pain and non-healing ulcers. Currently, the …

Extracellular vesicles (EVs) are known as molecular carriers involved in cell communication
and the regulation of (patho) physiological processes. miRNAs and growth factors are the …

Diabetes is a key risk factor for ischaemic foot disease, which causes pain, tissue loss,
hospital admission, and major amputation. Currently, treatment focuses on …

Limited efficacy of clinical interventions for peripheral arterial disease necessitates a better
understanding of the environmental and genetic determinants of tissue pathology. Existing …